Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sunflower Pharmaceutical Group Jizhou is a key manufacturing and research subsidiary of the Sunflower Pharmaceutical Group, one of China's leading pharmaceutical companies. Established through the acquisition of local pharmaceutical assets in Hebei, the company specializes in Traditional Chinese Medicine (TCM) and small molecule drugs. Its product portfolio is heavily weighted toward pediatric care, respiratory health, and digestive treatments, featuring several well-known over-the-counter (OTC) brands. The company operates large-scale, GMP-certified facilities capable of producing various dosage forms, including granules, tablets, and capsules. Sunflower Pharmaceutical Group Jizhou plays a vital role in the parent group's 'Little Sunflower' brand strategy, which focuses on the children's medicine market in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sunflower Pharmaceutical Group Jizhou.